Here is What to Know Beyond Why McKesson Corporation (MCK) is a Trending Stock
Sales of Pharmaceuticals, GLP-1s Send McKesson Shares to New Highs
3 Reasons Why Growth Investors Shouldn't Overlook McKesson (MCK)
JP Morgan Maintains Overweight on McKesson, Raises Price Target to $1255
McKesson Consensus Price Target Raised 10% to $1,157.23
5 insightful analyst questions from McKesson’s Q3 CY2026 earnings call
McKesson (MCK) Plans Medical Surgical Spin Off With $1.25 Billion Backing
McKesson (MCK) Upgraded to Buy: Here's What You Should Know
McKesson Corporation (MCK) Hit a 52 Week High, Can the Run Continue?
UBS Maintains Buy on McKesson, Raises Price Target to $1250
McKesson Corp.: Normalized Earnings Suggest Attractive Valuation
MCK Q2 Earnings Call Highlights Raised Outlook and Specialty Growth
TD Cowen Maintains Buy on McKesson, Raises Price Target to $1200
Leerink Partners Maintains Outperform on McKesson, Raises Price Target to $1200
RBC Capital Maintains Sector Perform on McKesson, Raises Price Target to $965
Evercore ISI Group Maintains Outperform on McKesson, Raises Price Target to $1200
McKesson Corp (MCK) (Q2 2027) Earnings Call Highlights: Raised Guidance, GLP-1 Momentum, and ...
McKesson Corporation Reports Fiscal 2027 Second Quarter Results and Raises Full Year Adjusted EPS Guidance
McKesson (NYSE:MCK) Posts Q2 EPS Beat, In-Line Revenue, and Raises Outlook
McKesson’s (NYSE:MCK) Q3 CY2026 adjusted EPS top estimates
Sign up for free to unlock this feature.
Creating your account...
Your account has been created. Redirecting...
Loading...
This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.